Litcius/Paper detail

Addressing high placebo response rates in randomized clinical trials for hidradenitis suppurativa

Amit Garg, Nicole Mastacouris, John R Ingram, Andrew Strunk

2023British Journal of Dermatology12 citationsDOI

Abstract

Journal Article Accepted manuscript Addressing High Placebo Response Rates in Randomized Clinical Trials for Hidradenitis Suppurativa Get access Amit Garg, Amit Garg Department of Dermatology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, New York, USA Corresponding author: Amit Garg, MD Email:[email protected] https://orcid.org/0000-0003-0886-6856 Search for other works by this author on: Oxford Academic Google Scholar Nicole Mastacouris, Nicole Mastacouris Department of Dermatology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, New York, USA Search for other works by this author on: Oxford Academic Google Scholar John R Ingram, John R Ingram Division of Infection and Immunity, Cardiff University, University Hospital of Wales, Heath Park, Cardiff, UK https://orcid.org/0000-0002-5257-1142 Search for other works by this author on: Oxford Academic Google Scholar Andrew Strunk Andrew Strunk Department of Dermatology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, New York, USA Search for other works by this author on: Oxford Academic Google Scholar British Journal of Dermatology, ljad375, https://doi.org/10.1093/bjd/ljad375 Published: 27 September 2023 Article history Received: 09 May 2023 Revision received: 31 July 2023 Accepted: 26 September 2023 Published: 27 September 2023

Topics & Concepts

MedicineHidradenitis suppurativaLibrary scienceClassicsHistoryInternal medicineComputer scienceDiseaseHidradenitis Suppurativa and TreatmentsColorectal and Anal CarcinomasChemotherapy-related skin toxicity
Addressing high placebo response rates in randomized clinical trials for hidradenitis suppurativa | Litcius